TY  - GEN
AU  - Govindan,Ramaswamy
AU  - Szczesna,Aleksandra
AU  - Ahn,Myung-Ju
AU  - Schneider,Claus-Peter
AU  - Gonzalez Mella,Pablo Fernando
AU  - Barlesi,Fabrice
AU  - Han,Baohui
AU  - Ganea,Doina Elena
AU  - Von Pawel,Joachim
AU  - Vladimirov,Vladimir
AU  - Fadeeva,Natalia
AU  - Lee,Ki Hyeong
AU  - Kurata,Takayasu
AU  - Zhang,Li
AU  - Tamura,Tomohide
AU  - Postmus,Pieter E
AU  - Jassem,Jacek
AU  - O'Byrne,Kenneth
AU  - Kopit,Justin
AU  - Li,Mingshun
AU  - Tschaika,Marina
AU  - Reck,Martin
TI  - Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer
SN  - 1527-7755
PY  - 2017///1030
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anemia
KW  - chemically induced
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Diarrhea
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Ipilimumab
KW  - Kaplan-Meier Estimate
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neutropenia
KW  - Outcome Assessment, Health Care
KW  - methods
KW  - Paclitaxel
KW  - Proportional Hazards Models
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study
UR  - https://doi.org/10.1200/JCO.2016.71.7629
ER  -